Future of dendritic cell vaccines for glioblastoma

Daniela Bota, MD, PhD, The University of California, Irvine, Irvine, CA, discusses the challenges of developing immunotherapy for glioblastoma and how dendritic cell vaccines could be useful, as well as other future directions for research in this area. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.